Introduction From a prospective multicentre multicountry clinical trial, we developed and validated risk models to predict prospective all-cause mortality and hospitalizations because of heart failure (HF) in patients with HF.Methods and results BIOSTAT-CHF is a research programme designed to develop and externally validate risk models to predict all-cause mortality and HF hospitalizations. The index cohort consisted of 2516 patients with HF from 69 centres in 11 European countries. The external validation cohort consisted of 1738 comparable patients from six centres in Scotland, UK. Patients from the index cohort had a mean age of 69 years, 27% were female, 83% were in New York Heart Association (NYHA) class II-III and the mean left ventri...
Aims: Several models for predicting the prognosis of heart failure (HF) patients have been developed...
Importance: Accurate prediction of risk of death or hospitalizations in patients with heart failure...
Background: The prediction of outcomes in patients with heart failure (HF) may inform prognosis, cli...
Introduction From a prospective multicentre multicountry clinical trial, we developed and validated ...
INTRODUCTION: From a prospective multicentre multicountry clinical trial, we developed and validated...
Aims Several models for predicting the prognosis of heart failure (HF) patients have been developed,...
Aims: The aim of this study was to generate a biomarker-driven prognostic tool for patients with chr...
BACKGROUND: Prognostic models developed in general cohorts with a mixture of heart failure (HF) phen...
Aims: Several models for predicting the prognosis of heart failure (HF) patients have been developed...
Importance: Accurate prediction of risk of death or hospitalizations in patients with heart failure...
Background: The prediction of outcomes in patients with heart failure (HF) may inform prognosis, cli...
Introduction From a prospective multicentre multicountry clinical trial, we developed and validated ...
INTRODUCTION: From a prospective multicentre multicountry clinical trial, we developed and validated...
Aims Several models for predicting the prognosis of heart failure (HF) patients have been developed,...
Aims: The aim of this study was to generate a biomarker-driven prognostic tool for patients with chr...
BACKGROUND: Prognostic models developed in general cohorts with a mixture of heart failure (HF) phen...
Aims: Several models for predicting the prognosis of heart failure (HF) patients have been developed...
Importance: Accurate prediction of risk of death or hospitalizations in patients with heart failure...
Background: The prediction of outcomes in patients with heart failure (HF) may inform prognosis, cli...